Tag: Dermatologic Surgery

All

Long Shot: Revance’s RT002 May Banish Frown Lines for 7 Months

Revance's investigational injectable—RT002—achieves median duration of 7 months, a phase 2 active comparator study now underway.

Hot Stuff: February 2015
Xeomin Versus Botox Study for Furrows: It’s a Draw
ASDSA Launches Patient Safety Database to Gather Adverse Events During Dermatologic Surgery Procedures
Knowing Your Risk for Skin Cancer May Limit Unhealthy Behaviors

All

Sorry, No Posts Found

All

How Persana Aims to Bring Transparency and Trust to Plastic Surgery Surgery in the Digital Age

Persana CEO Traci Inglis speaks with Plastic Surgery Practice about how the platform is addressing patient safety concerns by connecting users with board-certified aesthetic physicians in an increasingly unregulated digital landscape.

Next-Gen Fraxel Laser Launches with Upgraded Design and Treatment Efficiency
New Short-Term Botox-Like Treatment Moves Closer to FDA Review
Candela Launches Dual-Wavelength Laser for Vascular and Dermatologic Conditions

Tag: Dermatologic Surgery

All

Long Shot: Revance’s RT002 May Banish Frown Lines for 7 Months

Hot Stuff: February 2015

Xeomin Versus Botox Study for Furrows: It’s a Draw

ASDSA Launches Patient Safety Database to Gather Adverse Events During Dermatologic Surgery Procedures

Knowing Your Risk for Skin Cancer May Limit Unhealthy Behaviors

All

Sorry, No Posts Found

All

How Persana Aims to Bring Transparency and Trust to Plastic Surgery Surgery in the Digital Age

Next-Gen Fraxel Laser Launches with Upgraded Design and Treatment Efficiency

New Short-Term Botox-Like Treatment Moves Closer to FDA Review

Candela Launches Dual-Wavelength Laser for Vascular and Dermatologic Conditions

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links